Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 361 Precursor Cell Lymphoblastic Leukemia-Lymphoma 328 Lymphoma 297 Leukemia 254 Multiple Myeloma 246 Leukemia, Myeloid, Acute 241 Lymphoma, Non-Hodgkin 240 Lymphoma, Large B-Cell, Diffuse 238 Leukemia, Lymphocytic, Chronic, B-Cell 220 Myelodysplastic Syndromes 184 Lymphoma, Follicular 176 Hodgkin Disease 165 Lymphoma, Mantle-Cell 163 Burkitt Lymphoma 160 Lymphoma, B-Cell, Marginal Zone 117 Recurrence 115 Lymphoma, Large-Cell, Immunoblastic 95 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82 Myeloproliferative Disorders 81 Melanoma 78 Neoplasms, Plasma Cell 77 Leukemia, Myeloid, Chronic-Phase 72 Hematologic Neoplasms 72 Leukemia, Myeloid, Accelerated Phase 71 Leukemia, Myelomonocytic, Chronic 69 Lymphoma, B-Cell 65 Dendritic Cell Sarcoma, Interdigitating 64 Triple Negative Breast Neoplasms 63 Ovarian Neoplasms 61 Congenital Abnormalities 59

Interventions

Etoposide 2 Carboplatin 2 tremelimumab 1 etoposide phosphate 1 durvalumab 1 Photochemotherapy 1 Paclitaxel 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Drug Therapy 1 Dihematoporphyrin Ether 1 Cyclophosphamide 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Germinoma × Cyclophosphamide × Clear all

NCT02782754 2016-05-25

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Samsung Medical Center

Phase 2 Unknown

Germinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡